Photo via The Independent

Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant

Read the original at The Independent ↗
Cite

Chapman, M. (2026, September 15). Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant. The Independent. https://www.independent.co.uk/news/world/americas/abbott-baby-formula-fda-michigan-b3050098.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

The Independent · collected 2026-09-15 · by Michelle Chapman

Quick Summary

Abbott Laboratories has agreed to pay $385 million to settle legal claims related to a 2022 baby formula shortage caused by a recall at its Sturgis, Michigan plant. The Justice Department initiated a lawsuit amid concerns over bacterial contamination, leading to a nationwide recall of Abbott's major infant formula brands like Similac and exacerbating existing supply chain issues. While the settlement does not admit fault, Abbott emphasized that no unopened, distributed products tested positive for harmful bacteria. The company had shut down then reopened the plant following an FDA investigation.
Written by AI on 2026-09-15, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Abbott Laboratories, a major baby formula manufacturer, agreed to pay $385 million to settle civil False Claims Act cases with the U.S. Justice Department and several states over bacterial contamination at its largest plant in Sturgis, Michigan. The settlement resolves claims that powdered infant formula made at this facility was contaminated with Cronobacter bacteria during manufacturing, posing a risk to public health. This case followed a 2022 recall of Abbott's products after four infants fell ill from consuming the formula manufactured there. The Justice Department initially sought felony charges but later opted for a civil resolution under pressure from senior leadership. Despite this settlement, Abbott maintains it did not admit liability or fault and emphasizes no unopened distributed product tested positive for bacteria. The plant closure exacerbated existing supply shortages caused by disruptions during the COVID-19 pandemic.

Written for “Abbott Formula Settlement” on 2026-10-31, grounded in this article and the 4 other(s) covering the same event.

Story

📰 Abbott Formula Settlement
Economy/Business · 5 article(s) covering the same event. Compare every outlet's account →

Compared with similar articles

This article reads centre and hedges 12% of its claims. Each row says how that neighbour differs.
ABC News (US)
⚖️ Leans left further left than this Hedges 1 of 9 claims Outlet record 70/100
UPI
Hedges 4 of 13 claims Outlet record 56/100
CBS News
Hedges 4 of 14 claims Outlet record 66/100
Toronto Star
Hedges 1 of 2 claims Outlet record 64/100
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
8
sentences that state something as happening or true
Uncertain
12%
1 of 8 hedged ("reportedly", "may", "according to")
Leaning
Centre
of the writing, not the subject · beta estimate
Publisher signals
59/100
The Independent's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
5
Economy/Business
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-15 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Independent · 3448 article(s) · 7 correction(s) detected
Running correction rate · 7 correction(s)

Who wrote this

Michelle Chapman
8 article(s) here · 1 carrying a prediction
🔮 In May, Microsoft planned to offer buyouts to about 8,750 people, or 7% of its US workforce, according to two people familiar with the plan who were not authorized to speak about it publicly.
🔮 The economy, inflation and how those forces could impact the lives of Americans were front and center over the past week.
🔮 The Brightline companies that bet more than $5 billion on developing the nation’s only privately held passenger railroad are reworking their debt in bankruptcy court, but the bright yellow trains will continue running between Miami and Orlando.
🔮 Buffett, 96, will assume the role of chairman emeritus immediately, the company announced on Friday.
🔮 Buffett, 96, will become chairman emeritus and will take on his new role immediately, the company said Friday.
🔮 Abbott Laboratories will pay $385 million to resolve legal claims arising from a contamination inquiry at its baby formula manufacturing plant in Sturgis, Michigan, the nation's largest, which triggered severe supply shortages in 2022.
🔮 Drivers seeking to save money by purchasing motor oil to complete their own vehicle oil changes may view the move as another financial strain, while already dealing with elevated grocery bills and widespread concerns over ongoing inflation.
🔮 Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan, the largest in the country, which led to the supply shortages in 2022.
Also by Michelle Chapman
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 8 articles by Michelle Chapman →

Topics

Abbott Abbott Laboratories Michigan Sturgis the Justice Department

Subjects

Abbott PERSON · 4× the Justice Department ORG · 2× Abbott Laboratories ORG · 1× Biden PERSON · 1× Donald Trump PERSON · 1× Michigan GPE · 1× Sturgis GPE · 1× U.S. GPE · 1× the Food and Drug Administration ORG · 1×

Narrative

Concerns regarding the facility resulted in a lawsuit by the Justice Department alongside a sweeping recall of powdered formula products. Affecting multiple major lines such as Similac, the recall further strained inventory already burdened by supply chain bottlenecks and stockpiling during COVID-19 shutdowns.
framing: assertive · carried by 1 article(s) · first seen 2026-09-15
🔮 Abbott Laboratories will pay $385 million to resolve legal claims arising from a contamination inquiry at its baby formula manufacturing plant in Sturgis, Michigan, the nation's largest, which triggered severe supply shortages in 2022.

Claims (8 extracted, 1 hedged)

Abbott Laboratories will pay $385 million to resolve legal claims arising from a contamination inquiry at its baby formula manufacturing plant in Sturgis, Michigan, the nation's largest, which triggered severe supply shortages in 2022. uncertain
which → pay → 2022
Concerns regarding the facility resulted in a lawsuit by the Justice Department alongside a sweeping recall of powdered formula products. Affecting multiple major lines such as Similac, the recall further strained inventory already burdened by supply chain bottlenecks and stockpiling during COVID-19 shutdowns. asserted
recall → regard → shutdowns
The settlement covers litigation initiated by specific relators as well as the Attorneys General of multiple states, though Abbott stated the resolution contains no finding of fault or liability. asserted
resolution → cover → fault
Abbott stated on Monday that regulatory tests on unopened formula retrieved from homes of infants investigated during the 2022 recall were negative for Cronobacter sakazakii, a bacterium that can cause illness in infants. asserted
that → state → infants
Furthermore, the company emphasized that no unopened, distributed Abbott formula products have ever tested positive for the bacteria. asserted
products → emphasize → bacteria
A criminal investigation into the matter conducted by the Justice Department under President Donald Trump has since been closed. asserted
investigation → conduct → Trump
To address the shortage, the Biden administration relaxed import rules for foreign manufacturers, airlifted formula from Europe, and invoked federal emergency regulations to prioritize U.S. production. asserted
administration → address → production
Abbott closed the Sturgis facility in February 2022 following the start of an investigation by the Food and Drug Administration, before reopening it in June of that year. asserted
Abbott → close → year
💬Give feedback
🕘History 🎫Support